about
Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malariaSafety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatmentMurine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipineAutoimmunity and malaria: what are they doing together?Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA.Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.CD4+ T cells apoptosis in Plasmodium vivax infection is mediated by activation of both intrinsic and extrinsic pathwaysPhenotypic profiling of CD8(+) T cells during Plasmodium vivax blood-stage infection.Molecular Characterization of Giardia lamblia: First Report of Assemblage B in Human Isolates from Rio de Janeiro (Brazil).Geospatial distribution of intestinal parasitic infections in Rio de Janeiro (Brazil) and its association with social determinantsOn the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease.Associations of Giardia lamblia assemblages with HIV infections and symptomatology: HIV virus and assemblage B were they born to each other?Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro: a molecular epidemiological investigation.Dengue infection as a potential trigger of an imported Plasmodium ovale malaria relapse or a long incubation period in a non-endemic malaria region.New multilocus genotypes of Giardia lamblia human isolates.Intestinal helminth coinfection is associated with mucosal lesions and poor response to therapy in American tegumentary leishmaniasis.Cerebral tissue oxygenation impairment during experimental cerebral malaria.Longitudinal clinical and serological survey of abdominal angiostrongyliasis in Guaporé, southern Brazil, from 1995 to 1999.Enteroparasitosis prevalence and parasitism influence in clinical outcomes of tuberculosis patients with or without HIV co-infection in a reference hospital in Rio de Janeiro (2000-2006).NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.CLINICAL AND IMMUNOLOGICAL PROFILES OF ANAEMIA IN CHILDREN AND ADOLESCENTS WITH PLASMODIUM VIVAX MALARIA IN THE PARÁ STATE, BRAZILIAN AMAZON.[Abdominal angiostrongyliasis: its prevention by the destruction of infecting larvae in food treated with salt, vinegar or sodium hypochlorite]Inexpensive alternative material for the isolation of larvae with the Baermann method
P50
Q27334444-B558DB6C-B4DE-48E6-A9F7-D3C7228AF1C7Q28595615-3C122497-02E6-4DB6-9626-4562ED75EDEFQ33703727-49D34B1B-32A8-461A-BF25-64BD5373318DQ34023782-19642364-6411-482F-A140-24C14D29BD49Q34163836-56F32ED7-6788-4901-80F7-2CDD279B9487Q35054703-6D9EA98E-39FB-46C2-A01F-70FB8D788248Q35078503-E5AEADDD-B750-43B0-9292-62DED4570C08Q35085645-33697D1C-4170-4EE4-A075-A2BB0B60C893Q36102592-93AA94AB-1A5F-475D-8E50-40121389A077Q36300641-4817E8FD-F62C-49A1-95E8-6682CC0D0E03Q37602748-747EABB3-5F58-4664-B45E-812830A80A40Q38812779-81C49452-D5E6-40D0-9CDE-5D4A7B00C99CQ38919954-F1ABD4F8-3CD5-4695-8BC7-56DDED2114B2Q40121169-89F9D437-55C3-45F1-B79C-FF0B403EC25DQ40150142-BDBA91EC-CCB2-4D2C-B085-25EE49F4FA9FQ40929399-01A55DBB-875A-46D1-A400-6F5B08109CBCQ41946015-27BAC4F3-84C0-4F5E-8AB8-0678013776A8Q43219062-BCCEDD79-B68E-4914-A12E-8A1CE1522209Q44271618-286574E2-2F42-45FA-BE92-40E00332699DQ46227638-E9B64244-B781-4A83-8661-457B72D72660Q50058479-5D17E1F0-1220-4276-BC8B-2C6F84FD9ACBQ71156649-A17B922A-1AEF-4465-B455-D09DC9D1D8F8Q73793785-17659633-780B-448E-A4D4-60533A86E783
P50
description
researcher ORCID ID = 0000-0003-4466-3124
@en
wetenschapper
@nl
name
Graziela Maria Zanini
@ast
Graziela Maria Zanini
@en
Graziela Maria Zanini
@es
Graziela Maria Zanini
@nl
type
label
Graziela Maria Zanini
@ast
Graziela Maria Zanini
@en
Graziela Maria Zanini
@es
Graziela Maria Zanini
@nl
prefLabel
Graziela Maria Zanini
@ast
Graziela Maria Zanini
@en
Graziela Maria Zanini
@es
Graziela Maria Zanini
@nl
P106
P21
P31
P496
0000-0003-4466-3124